Common Contracts
1 similar null contracts
XENETIC BIOSCIENCES, INC.New York • November 19th, 2021
Xenetic Biosciences, Inc. has entered into an At The Market Offering Agreement (the “Sales Agreement”) with H.C. Wainwright & Co., LLC (“Wainwright”), as sales agent, relating to the offer and sale of up to $4,000,000 of shares of our common stock, par value $0.001 per share, offered by this prospectus supplement and the accompanying prospectus.
